cd38 inhibitor synergy with nnmt inhibitor 5-amino-1mq nad+ inhibition counteracts tubular senescence and fibrosis in early stages of chronic kidney disease: Cell Reports Nicotinamide N-Methyltransferase (NNMT) and Liver
Nicotinamide N Methyltransferase (NNMT) and Liver Cancer: From Metabolic Networks to Therapeutic Targets A Potent and Specific CD38 Inhibitor Ameliorates Age Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline: Cell Metabolism Targeting CD38 dependent NAD+ metabolism to mitigate multiple organ fibrosis ScienceDirect US20200102274A1 Quinoline derived small molecule inhibitors of nicotinamide n methyltransferase (nnmt) and uses thereof Google Patents
Pay in 4 interest-free payments of $7.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



